ASCO Congratulates NIH Director Francis Collins on Remaining in Critical Leadership Position

Statement by ASCO President Bruce E. Johnson, MD, FASCO
For immediate release
June 8, 2017


Rachel Martin

“The American Society of Clinical Oncology (ASCO) congratulates Francis S. Collins, MD, PhD, on the announcement of his continued service as the Director of the National Institutes of Health (NIH). A renowned researcher and skilled administrator, Dr. Collins appreciates the critical role that federal research plays in advancing our understanding of how to prevent, diagnose, and treat cancer and other life-threatening diseases, and has worked tirelessly to ensure that the United States remains at the forefront of biomedical innovation.

“Under the careful guidance of Dr. Collins, the NIH has embarked on a number of new initiatives to modernize and improve biomedical research. He will play a critical role in implementing the 21st Century Cures Act, which gave the NIH new funding and authority to support vital cancer research, including through the Beau Biden Cancer Moonshot and the Precision Medicine initiatives.

“ASCO looks forward to continuing our work with the NIH and the National Cancer Institute on advancing federally supported basic and translational research and publicly funded clinical trials, which give hope to millions of Americans with cancer and their families.” 

About ASCO: 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at, explore patient education resources at Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube. Visit ASCO in Action for the latest cancer-policy developments and read our cancer policy issue briefs for an overview of key policy issues.